Intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in recurrent ovarian carcinoma patients (a phase I study)

INTRODUCTION: Recurrent ovarian carcinoma has dismal prognosis, but control of disease and prolonged survival are possible in some patients. The estimated 5-year survival is 46% for all stages of ovarian cancer, and only 28% for metastasized disease. Notably, the majority of women with ovarian cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogstad-van Evert, Janneke, Bekkers, Ruud, Ottevanger, Nelleke, Schaap, Nicolaas, Hobo, Willemijn, Jansen, Joop H., Massuger, Leon, Dolstra, Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380776/
https://www.ncbi.nlm.nih.gov/pubmed/30702598
http://dx.doi.org/10.1097/MD.0000000000014290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380776/
https://www.ncbi.nlm.nih.gov/pubmed/30702598
http://dx.doi.org/10.1097/MD.0000000000014290

Ejemplares similares